Samuel Whiting
2023
In 2023, Samuel Whiting earned a total compensation of $3.4M as Chief Medical Officer at OvaScience, a 306% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $199,971 |
|---|---|
| Option Awards | $2,717,298 |
| Salary | $454,480 |
| Other | $13,200 |
| Total | $3,384,949 |
Whiting received $2.7M in option awards, accounting for 80% of the total pay in 2023.
Whiting also received $200K in non-equity incentive plan, $454.5K in salary and $13.2K in other compensation.
Rankings
In 2023, Samuel Whiting's compensation ranked 242nd out of 2,918 executives tracked by ExecPay. In other words, Whiting earned more than 91.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 242 out of 2,918 | 92nd |
Division Manufacturing | 131 out of 1,608 | 92nd |
Major group Chemicals And Allied Products | 93 out of 901 | 90th |
Industry group Drugs | 91 out of 864 | 90th |
Industry Pharmaceutical Preparations | 58 out of 622 | 91st |
Source: SEC filing on April 23, 2024.
Whiting's colleagues
We found two more compensation records of executives who worked with Samuel Whiting at OvaScience in 2023.